BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12140786)

  • 1. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA).
    Manor I; Tyano S; Mel E; Eisenberg J; Bachner-Melman R; Kotler M; Ebstein RP
    Mol Psychiatry; 2002; 7(6):626-32. PubMed ID: 12140786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype.
    Eisenberg J; Mei-Tal G; Steinberg A; Tartakovsky E; Zohar A; Gritsenko I; Nemanov L; Ebstein RP
    Am J Med Genet; 1999 Oct; 88(5):497-502. PubMed ID: 10490706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW; Kim BN; Cho SC
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA).
    Manor I; Tyano S; Eisenberg J; Bachner-Melman R; Kotler M; Ebstein RP
    Mol Psychiatry; 2002; 7(7):790-4. PubMed ID: 12192625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No allele variation of the MAOA gene promoter in male Chinese subjects with attention deficit hyperactivity disorder.
    Lung FW; Yang P; Cheng TS; Kao WT
    Neuropsychobiology; 2006; 54(3):147-51. PubMed ID: 17230031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder.
    Manor I; Eisenberg J; Tyano S; Sever Y; Cohen H; Ebstein RP; Kotler M
    Am J Med Genet; 2001 Jan; 105(1):91-5. PubMed ID: 11425009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: evidence of association with the -521 C/T SNP.
    Yang JW; Jang WS; Hong SD; Ji YI; Kim DH; Park J; Kim SW; Joung YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):243-8. PubMed ID: 17850946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele.
    Ohadi M; Shirazi E; Tehranidoosti M; Moghimi N; Keikhaee MR; Ehssani S; Aghajani A; Najmabadi H
    Brain Res; 2006 Jul; 1101(1):1-4. PubMed ID: 16782077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of significant association between -1021C-->T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder.
    Bhaduri N; Mukhopadhyay K
    Neurosci Lett; 2006 Jul; 402(1-2):12-6. PubMed ID: 16616989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of susceptibility loci located within Xp11 in attention deficit hyperactivity disorder].
    Jiang S; Xin R; Qian Y; Lin S; Li F; Wu X; Wang D; Tang G; Jiang K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):169-72. PubMed ID: 11402442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis.
    Kent L; Doerry U; Hardy E; Parmar R; Gingell K; Hawi Z; Kirley A; Lowe N; Fitzgerald M; Gill M; Craddock N
    Mol Psychiatry; 2002; 7(8):908-12. PubMed ID: 12232786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the dopamine D4 receptor gene variants in attention deficit hyperactivity disorder].
    Kereszturi E; Király O; Csapó Z; Tárnok Z; Gádoros J; Sasvári-Székely M; Nemoda Z
    Neuropsychopharmacol Hung; 2007 Mar; 9(1):11-8. PubMed ID: 17879560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples.
    Xu X; Brookes K; Chen CK; Huang YS; Wu YY; Asherson P
    BMC Psychiatry; 2007 Feb; 7():10. PubMed ID: 17328795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pedigree disequilibrium test (PDT) replicates association and linkage between DRD4 and ADHD in multigenerational and extended pedigrees from a genetic isolate.
    Arcos-Burgos M; Castellanos FX; Konecki D; Lopera F; Pineda D; Palacio JD; Rapoport JL; Berg K; Bailey-Wilson J; Muenke M
    Mol Psychiatry; 2004 Mar; 9(3):252-9. PubMed ID: 15094785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.
    Ribasés M; Ramos-Quiroga JA; Hervás A; Bosch R; Bielsa A; Gastaminza X; Artigas J; Rodriguez-Ben S; Estivill X; Casas M; Cormand B; Bayés M
    Mol Psychiatry; 2009 Jan; 14(1):71-85. PubMed ID: 17938636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder.
    Schulze TG; Müller DJ; Krauss H; Scherk H; Ohlraun S; Syagailo YV; Windemuth C; Neidt H; Grässle M; Papassotiropoulos A; Heun R; Nöthen MM; Maier W; Lesch KP; Rietschel M
    Am J Med Genet; 2000 Dec; 96(6):801-3. PubMed ID: 11121185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample.
    Cornish KM; Manly T; Savage R; Swanson J; Morisano D; Butler N; Grant C; Cross G; Bentley L; Hollis CP
    Mol Psychiatry; 2005 Jul; 10(7):686-98. PubMed ID: 15809660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.